Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways
Behavioural Neurology · 2023
DOI: 10.1155/2023/1857330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Neurology, 2023. Verfasst von Qi Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Alzheimer Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuxi Health and Family Planning Commission, National Natural Science Foundation of China, Heilongjiang University of Chinese Medicine.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common form of dementia and a significant social and economic burden. Estrogens can exert neuroprotective effects and may contribute to the prevention, attenuation, or even delay in the onset of AD; however, long-term estrogen therapy is associated with harmful side effects. Thus, estrogen alternatives are of interest for countering AD. Naringin, a phytoestrogen, is a key active ingredient in the traditional Chinese medicine Drynaria. Naringin is known to protect against nerve injury induced by amyloid beta-protein (Aβ) 25–35, but the underlying mechanisms of this protection are unclear. To investigate the mechanisms of naringin neuroprotection, we observed the protective effect on Aβ25–35-injured C57BL/6J mice’s learning and memory ability and hippocampal neurons. Then, an Aβ25–35 injury model was established with adrenal phaeochromocytoma (PC12) cells. We examined the effect of naringin treatment on Aβ25–35-injured PC12 cells and its relationship with estrogen receptor (ER), phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), and glycogen synthase kinase (GSK)-3β signaling pathways. Estradiol (E2) was used as a positive control for neuroprotection. Naringin treatment resulted in improved learning and memory ability, the morphology of hippocampal neurons, increased cell viability, and reduced apoptosis. We next examined the expression of ERβ, p-AKT (Ser473, Thr308), AKT, p-GSK-3β (Ser9), GSK-3β, p-Tau (Thr231, Ser396), and Tau in PC12 cells treated with Aβ25–35 and either naringin or E2, with and without inhibitors of the ER, PI3K/AKT, and GSK-3β pathways. Our results demonstrated that naringin inhibits Aβ25–35-induced Tau hyperphosphorylation by modulating the ER, PI3K/AKT, and GSK-3β signaling pathways. Furthermore, the neuroprotective effects of naringin were comparable to those of E2 in all treatment groups. Thus, our results have furthered our understanding of naringin’s neuroprotective mechanisms and indicate that naringin may comprise a viable alternative to estrogen therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, China.
- College of Jiamusi, Heilongjiang University of Chinese Medicine, Jiamusi, Heilongjiang 154007, China.
- Hospital of Traditional Chinese Medicine, Wuxi, Jiangsu 214071, China.
- Department of Pharmacy, Higher Health Vocational Technology School, Wuxi 214000, China.
- Chinese Medicine & Postdoctoral Mobile Research Station, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
ORCID-Profile: Hongdan Xu, Ning Zhang
Förderung
- Wuxi Health and Family Planning Commission
- National Natural Science Foundation of China
- Heilongjiang University of Chinese Medicine
- Heilongjiang Touyan Innovation Team Program
Zitieren
APA
Qiu, Q., Lei, X., Wang, Y., Xiong, H., Xu, Y., Sun, H., Xu, H., & Zhang, N. (2023). Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways. Behavioural Neurology. https://doi.org/10.1155/2023/1857330
Vancouver
Qiu Q, Lei X, Wang Y, Xiong H, Xu Y, Sun H, et al. Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways. Behavioural Neurology. 2023. doi:10.1155/2023/1857330
BibTeX
@article{Qiu2023,
author = {Qiu, Qi and Lei, Xia and Wang, Yueying and Xiong, Hui and Xu, Yanming and Sun, Huifeng and Xu, Hongdan and Zhang, Ning},
title = {Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways},
journal = {Behavioural Neurology},
year = {2023},
doi = {10.1155/2023/1857330}
}
EUVIMED